Your browser doesn't support javascript.
loading
Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.
Roy, Hemant K; Turzhitsky, Vladimir; Wali, Ramesh; Radosevich, Andrew J; Jovanovic, Borko; Della'Zanna, Gary; Umar, Asad; Rubin, David T; Goldberg, Michael J; Bianchi, Laura; De La Cruz, Mart; Bogojevic, Andrej; Helenowski, Irene B; Rodriguez, Luz; Chatterton, Robert; Skripkauskas, Silvia; Page, Katherine; Weber, Christopher R; Huang, Xiaoke; Richmond, Ellen; Bergan, Raymond C; Backman, Vadim.
Afiliação
  • Roy HK; Department of Medicine, Boston University Medical Center, Boston, Massachusetts, USA.
  • Turzhitsky V; Department of Biomedical Engineering, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Wali R; Department of Medicine, Boston University Medical Center, Boston, Massachusetts, USA.
  • Radosevich AJ; Department of Biomedical Engineering, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Jovanovic B; Department of Preventive Medicine, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Della'Zanna G; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
  • Umar A; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
  • Rubin DT; Department of Medicine, The University of Chicago Medical Center, Chicago, Illinois, USA.
  • Goldberg MJ; Department of Medicine, NorthShore University Health Systems, Evanston, Illinois, USA.
  • Bianchi L; Department of Medicine, NorthShore University Health Systems, Evanston, Illinois, USA.
  • De La Cruz M; Department of Medicine, Boston University Medical Center, Boston, Massachusetts, USA.
  • Bogojevic A; Department of Medicine, NorthShore University Health Systems, Evanston, Illinois, USA.
  • Helenowski IB; Department of Preventive Medicine, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Rodriguez L; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
  • Chatterton R; Department of Obstetrics and Gynecology, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Skripkauskas S; Department of Medicine, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Page K; Department of Medicine, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Weber CR; Department of Pathology, The University of Chicago Medical Center, Chicago, Illinois, USA.
  • Huang X; Department of Medicine, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Richmond E; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.
  • Bergan RC; Department of Medicine, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Backman V; Department of Biomedical Engineering, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.
Gut ; 66(2): 285-292, 2017 02.
Article em En | MEDLINE | ID: mdl-26503631
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article